PR Newswire BiotechnologyCodex · 实盘不做把握 9/10不做原因:无增量信息🔁 +1 同一事件
北京时间·🕒 发布 20:00:00·⟳ 抓取 20:00:39 +39s·⚡ 决策 08-31 20:03:42 +3m03s·57.3 天前
AbbVie将参加Wells Fargo年度医疗健康会议并进行炉边谈话
该公告只是会议日程和网络直播安排，不改变AbbVie基本面预期、证券供需或风险暴露；行情、供应链和历史先例不会改变不交易结论。
📄 原文PR Newswire Biotechnology↗ 原文
AbbVie to Present at the Wells Fargo 21st Annual Healthcare Conference
NORTH CHICAGO, Ill., Aug. 31, 2026 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the Wells Fargo 21st Annual…
不做 AbbVie（ABBV.US）
例行投资者会议出席预告，无新增业绩、监管、管线、订单或资本配置事实，无法形成正期望交易。
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
研究档案
结论摘要
AbbVie公告管理层将参加Wells Fargo医疗健康会议并做炉边谈话，信息本身只说明投资者沟通安排，没有披露新增数据、指引、审批、交易或商业化进展，因此对AbbVie（ABBV.US）为中性事件，不具备可执行的正负预期差。
🔎 新鲜度:最早出现 2026-08-31 · 扩散 low · price-in 风险 low ↗
主要风险
- 若会议当天管理层给出新的业绩、管线或资本配置表述，需要作为新事件另行研判。
先例如何影响了这次决策
对本次决策的影响:确认不因会议预告本身建立AbbVie方向性仓位。
方向:例行会议预告不具备明确方向，历史同类价格反应不构成本次交易依据。
涨幅量级:没有可量化业务增量，无法用先例校准涨跌幅。
形态:未进入方向性交易，先例研究不会改变结论。
原文全文
展开原文 · 1,098 字
AbbVie to Present at the Wells Fargo 21st Annual Healthcare Conference
NORTH CHICAGO, Ill., Aug. 31, 2026 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the Wells Fargo 21st Annual Healthcare Conference on Wednesday, September 9, 2026. Management will participate in a fireside chat at 9:15 a.m. Central time.
A live audio webcast of the presentation will be accessible through AbbVie's Investor Relations website at investors.abbvie.com. An archived edition of the session will be available later that day.
About AbbVie
AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas including immunology, neuroscience and oncology – and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on LinkedIn, Facebook, Instagram, X and YouTube.
Media: Catherine Langel |
Investors: Liz Shea |
SOURCE AbbVie
NORTH CHICAGO, Ill., Aug. 31, 2026 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the Wells Fargo 21st Annual Healthcare Conference on Wednesday, September 9, 2026. Management will participate in a fireside chat at 9:15 a.m. Central time.
A live audio webcast of the presentation will be accessible through AbbVie's Investor Relations website at investors.abbvie.com. An archived edition of the session will be available later that day.
About AbbVie
AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas including immunology, neuroscience and oncology – and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on LinkedIn, Facebook, Instagram, X and YouTube.
Media: Catherine Langel |
Investors: Liz Shea |
SOURCE AbbVie
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
这条决策早于决策账本(2026-10-08 起逐条追加),没有追加记录。